🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Completed
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2009-10
Trial ID
NCT01044433
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2008-04
Trial ID
NCT00657137
Treatments Being Tested
RATIONALE: Lapatinib ditosylate may stop the growth of tumor cells by block...
Status
Completed
Location
Centre Leon Berard
Start Date
2009-04
Trial ID
NCT00967031
Treatments Being Tested
Combining Erb inhibitors, such lapatinib, and TS inhibitors, such as capeci...
Status
Terminated
Location
CHARITÉ CAMPUS, VIRCHOW-KLINIKUM, UNIVERSITÄTSMEDIZIN BERLIN, Centrum 14, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie
Start Date
2010-06
Trial ID
NCT01145404
Treatments Being Tested
The purpose of this study is to estimate the clinical benefit of lapatinib ...
Status
Withdrawn
Location
Charite Campus Mitte II. Medizinische Klinik Hämatologie und Onkologie
Start Date
2013-09
Trial ID
NCT01985893
Treatments Being Tested
The purpose of this study is to find out how effective this combination is ...
Status
Completed
Location
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Start Date
2007-09
Trial ID
NCT00574171
Treatments Being Tested
Diarrhoea is the most commonly reported adverse event (AE) associated with ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-12-17
Trial ID
NCT02294786
Treatments Being Tested
The purpose of this study is to determine the highest, tolerated dose level...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-26
Trial ID
NCT00536809
Treatments Being Tested
Subjects with advanced or metastatic (spread to other parts of the body) br...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey at Hamilton
Start Date
2007-07-23
Trial ID
NCT00496366
Treatments Being Tested
The purpose of this research study is to determine how well neratinib works...
Status
Completed
Location
University of California, San Francisco Medical Center
Start Date
2012-02
Trial ID
NCT01494662
Treatments Being Tested